Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology


  1. 2024
  2. Published

    Reduced mitochondrial respiration in peripheral T cells after paediatric heamatopoietic stem cell transplantation

    Mølgaard, K., Kielsen, K., Ifversen, M., Met, Özcan, Svane, Inge Marie & Muller, Klaus, 2024, In: Frontiers in Immunology. 14, 1327977.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2023
  4. Published

    Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply

    Dahl, E. K., Abed, O. K., Kjeldsen, J., dqp123, dqp123, Svane, Inge Marie, Dige, A., Agnholt, J. S., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, Jan 2023, In: Alimentary Pharmacology and Therapeutics. 57, 1, p. 152-153 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  5. Published

     of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

    Hulen, T. M., Friese, C., Kristensen, N. P., Granhøj, J. S., Borch, T. H., Peeters, M. J. W., Donia, M., Andersen, Mads Hald, Hadrup, S. R., Svane, Inge Marie & Met, Özcan, 2023, In: Frontiers in Immunology. 14, 15 p., 1180997.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    ASO Visual Abstract: Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma-A National Cohort Study of 1480 Patients

    Helvind, N. M., Weitemeyer, M. B. M., Chakera, A. H., Hendel, Helle Westergren, Ellebæk, E., Svane, Inge Marie, Kjærskov, M. W., Bojesen, S., Skyum, H., Petersen, S. K., Bastholt, L., Johansen, Christoffer, Bidstrup, P. E. & Hølmich, Lisbet Rosenkrantz, 2023, In: Annals of Surgical Oncology. 30, 4, p. 2389-2390 2 p.

    Research output: Contribution to journalConference abstract in journalResearch

  7. Published

    An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial

    Grauslund, J. H., Holmström, M. O., Martinenaite, E., Lisle, T. L., Glöckner, H. J., Fassi, Daniel El , Klausen, U., Mortensen, R. E. J., Jørgensen, N., Kjær, L., Skov, V., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2023, In: Frontiers in Immunology. 14, 14 p., 1117466.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Combination therapy with immune check point inhibitors and acute kidney injury

    Valentin, A., Møller, A. K. H., Palshof, J. A., Broberg, B., Gravesen, E., Svane, Inge Marie & Hansen, Ditte, 2023, In: Acta Oncologica. 62, 2, p. 121-125 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published
  10. Published

    Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients

    Helvind, N. M., Weitemeyer, M. B. M., Chakera, A. H., Hendel, Helle Westergren, Ellebæk, E., Svane, Inge Marie, Kjærskov, M. W., Bojesen, S., Skyum, H., Petersen, S. K., Bastholt, L., Johansen, Christoffer, Bidstrup, P. E. & Hølmich, Lisbet Rosenkrantz, 2023, In: Annals of Surgical Oncology. 30, 4, p. 2377-2388 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer

    Mørk, S. K., Kongsted, P., Westergaard, M. C. W., Albieri, B., Granhøj, J. S., Donia, M., Martinenaite, E., Holmström, M. O., Madsen, K., Kverneland, A. H., Kjeldsen, J. W., Holmstroem, R. B., Lorentzen, C. L., Nørgaard, N., Andreasen, L. V., Wood, G. K., Christensen, D., Klausen, M. S., Hadrup, S. R., thor Straten, P. & 2 others, Andersen, Mads Hald & Svane, Inge Marie, 2023, In: Frontiers in Immunology. 14, 1122977.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy

    Schina, A., Sztupinszki, Z., Svane, Inge Marie, Szallasi, Z., Jönsson, G. & Donia, M., 2023, In: Journal for ImmunoTherapy of Cancer. 11, 8, 12 p., 006941.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply

    Dahl, E., Abed, O., Agnholt, J., Bjerrum, Jakob Tveiten , Dige, A., Kjeldsen, J., Svane, Inge Marie, Donia, M. & Seidelin, Jakob Benedict, 2023, In: Alimentary Pharmacology and Therapeutics. 57, 8, p. 918-919

    Research output: Contribution to journalComment/debateResearchpeer-review

  14. Published

    Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

    Lorentzen, C. L., Kjeldsen, J. W., Ehrnrooth, E., Andersen, M. H. & Svane, Inge Marie, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 5, 10 p., e006755.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy

    Borch, A., Bjerregaard, A. M., Araujo Barbosa de Lima, V., Østrup, O., Yde, C. W., Eklund, A. C., Mau-Sørensen, M., Barra, C., Svane, Inge Marie, Nielsen, Finn Cilius, Funt, S. A., Lassen, Ulrik Niels & Hadrup, S. R., 2023, In: Frontiers in Genetics. 14, 13 p., 1058605.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)

    Chen, I. M., Donia, M., Chamberlain, C. A., Jensen, Agnete Witness Præst, Draghi, A., Theile, S., Madsen, K., Hasselby, Jane Preuss, Toxværd, A., Høgdall, Estrid Vilma Solyom, Lorentzen, T., Wilken, E. E., Geertsen, P., Svane, Inge Marie, Johansen, Julia Sidenius & Nielsen, D., 2023, In: European Journal of Cancer. 180, p. 125-133 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

    Mortensen, R. E. J., Holmström, M. O., Lisle, T. L., Hasselby, Jane Preuss, Willemoe, G. L., Met, Özcan, Svane, Inge Marie, Johansen, Julia Sidenius, Nielsen, Dorte Lisbet, Chen, I. M. & Andersen, Mads Hald, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy

    Pedersen, S., Holmstroem, R. B., von Heymann, A., Tolstrup, L. K., Madsen, K., Petersen, M. A., Haslund, C. A., Ruhlmann, C. H., Schmidt, H., Johansen, Christoffer, Svane, Inge Marie & Ellebaek, E., 2023, In: Acta Oncologica. 62, 1, p. 62-69 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol

    Spindler, N. J., Persson, Gitte F., Theile, S., Nielsen, D. L., Høgdall, Estrid Vilma Solyom, Al-Farra, G., Hendel, Helle Westergren, Lorentzen, T., Svane, Inge Marie, Lindberg, H. & Eefsen, R. L., 2023, In: BMJ Open. 13, 1, 8 p., e063500.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Restoring tumor immunogenicity with dendritic cell reprogramming

    Zimmermannova, O., Ferreira, A. G., Ascic, E., Santiago, M. V., Kurochkin, I., Hansen, M., Met, Ö., Caiado, I., Shapiro, I. E., Michaux, J., Humbert, M., Soto-Cabrera, D., Benonisson, H., Silvério-Alves, R., Gomez-Jimenez, D., Bernardo, C., Bauden, M., Andersson, R., Höglund, M., Miharada, K. & 9 others, Nakamura, Y., Hugues, S., Greiff, L., Lindstedt, M., Rosa, F. F., Pires, C. F., Bassani-Sternberg, M., Svane, Inge Marie & Pereira, C. F., 2023, In: Science immunology. 8, 85, 20 p., eadd4817.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Seasonal variation in effect of anti-PD-1 initiation on overall survival among patients with advanced melanoma

    Ellebaek, E., Schina, A., Schmidt, H., Haslund, C. A., Bastholt, L., Svane, Inge Marie & dqp123, dqp123, 2023, In: Pigment Cell and Melanoma Research. 36, 2, p. 224-231

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Supervised clustering of peripheral immune cells associated with clinical response to checkpoint inhibitor therapy in patients with advanced melanoma

    Kverneland, Anders Handrup, Thorsen, S. U., Granhøj, J. S., Hansen, F. S., Konge, M., Ellebæk, E., Donia, M. & Svane, Inge Marie, 2023, In: Immuno-Oncology and Technology. 20, 10 p., 100396.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy

    Tvingsholm, S. A., Frej, M. S., Rafa, V. M., Hansen, U. K., Ormhøj, M., Tyron, A., Jensen, A. W. P., Kadivar, M., Bentzen, A. K., Munk, K. K., Aasbjerg, G. N., Ternander, J. S. H., Heeke, C., Tamhane, T., Schmess, C., Funt, S. A., Kjeldsen, J. W., Kverneland, A. H., Met, Ö., Draghi, A. & 4 others, Jakobsen, S. N., Donia, M., Svane, Inge Marie & Hadrup, S. R., 2023, In: Journal for ImmunoTherapy of Cancer. 11, 8, 16 p., e006847.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    TIL Therapy: Facts and Hopes

    Monberg, Tine Juul, Borch, T. H., Svane, Inge Marie & Donia, M., 2023, In: Clinical Cancer Research. 29, 17, p. 3275-3283 9 p.

    Research output: Contribution to journalReviewResearchpeer-review

  25. Published

    Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy

    Dolton, G., Rius, C., Wall, A., Szomolay, B., Bianchi, V., Galloway, S. A. E., Hasan, M. S., Morin, T., Caillaud, M. E., Thomas, H. L., Theaker, S., Tan, L. R., Fuller, A., Topley, K., Legut, M., Attaf, M., Hopkins, J. R., Behiry, E., Zabkiewicz, J., Alvares, C. & 13 others, Lloyd, A., Rogers, A., Henley, P., Fegan, C., Ottmann, O., Man, S., Crowther, M. D., Donia, M., Svane, Inge Marie, Cole, D. K., Brown, P. E., Rizkallah, P. & Sewell, A. K., 2023, In: Cell. 186, 16, p. 3333-3349.e27 45 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Accepted/In press

    “One more chance to survive”: the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy—a qualitative study and recommendations for future care

    Egeler, M. D., Boomstra, E., Rohaan, M. W., Van den Heuvel, N. M. J., Fraterman, I., Delfos, M., van de Poll-Franse, L. V., Borch, T. H., Svane, Inge Marie, Haanen, J. B. A. G., Retèl, V. P. & Boekhout, A. H., 2023, (Accepted/In press) In: Journal of Cancer Survivorship.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. 2022
  28. Published

    Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma

    Mork, S. K., Kadivar, M., Bol, K. F., Draghi, A., Westergaard, M. C. W., Skadborg, S. K., Overgaard, N., Sorensen, A. B., Rasmussen, I. S., Andreasen, L. V., Yde, C. W., Trolle, T., Garde, C., Friis-Nielsen, J., Norgaard, N., Christensen, D., Kringelum, J. V., dqp123, dqp123, Hadrup, S. R. & Svane, Inge Marie, 31 Dec 2022, In: OncoImmunology. 11, 1, 15 p., 2023255.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    Immune checkpoint inhibitor treatment and ophthalmologist consultations in patients with malignant melanoma or lung cancer—A nationwide cohort study

    D’Souza, M., Bagger, M., Alberti, M., Malmborg, M., Schou, Morten, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar, Svane, Inge Marie & Kiilgaard, Jens Folke, 1 Jan 2022, In: Cancers. 14, 1, 13 p., 49.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. Published

    Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

    Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial

    Lorentzen, C. L., Martinenaite, E., Kjeldsen, J. W., Holmstroem, R. B., Mørk, S. K., Pedersen, A. W., Ehrnrooth, E., Andersen, Mads Hald & Svane, Inge Marie, 2022, In: Frontiers in Immunology. 13, 1023023.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells

    Weis-Banke, S. E., Lisle, T. L., Perez Penco, Maria, Schina, A., Hübbe, M. L., Siersbæk, M., Holmström, M. O., Jørgensen, M. A., Svane, Inge Marie, Met, Özcan, Ødum, Niels, Madsen, Daniel Hargbøl, dqp123, dqp123, Grøntved, L. & Andersen, Mads Hald, 2022, In: Journal for ImmunoTherapy of Cancer. 10, 10, e005326.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?

    Lauss, M., dqp123, dqp123, Svane, Inge Marie & Jönsson, G., 2022, In: Clinical Cancer Research. 28, 9, p. 1751–1758 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis

    Holmstroem, R. B., Nielsen, Ole Haagen, Jacobsen, Søren, Riis, Lene Buhl, Theile, S., Bjerrum, Jakob Tveiten , Vilmann, Peter, Johansen, Julia Sidenius, Boisen, M. K., Eefsen, R. H. L., Svane, Inge Marie, Nielsen, Dorte Lisbet & Chen, I. M., 2022, In: Journal for ImmunoTherapy of Cancer. 10, 9

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. Published

    Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting

    Pedersen, S., Larsen, K. O., Christensen, Alex Hørby, Svane, Inge Marie, Zerahn, B. & Ellebaek, E., 2022, In: Acta Oncologica. 61, 1, p. 45-51

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    Clinical advances and ongoing trials on mRNA vaccines for cancer treatment

    Lorentzen, C. L., Haanen, J. B., Met, Özcan & Svane, Inge Marie, 2022, In: The Lancet Oncology. 23, 10, p. e450-e458

    Research output: Contribution to journalReviewResearchpeer-review

  37. Published

    Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma

    Ellebaek, E., Schina, A., Andersen, R., Hendel, Helle Westergren, Svane, Inge Marie & dqp123, dqp123, 2022, In: International Journal of Cancer. 150, 11, p. 1870-1878 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published

    Coexisting Alterations of MHC Class I Antigen Presentation and IFNg Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy

    Nielsen, M., Presti, M., Sztupinszki, Z., Jensen, Agnete Witness Præst, Draghi, A., Chamberlain, C. A., Schina, A., Yde, C. W., Wojcik, J., Szallasi, Z., Crowther, M. D., Svane, Inge Marie & Donia, M., 2022, In: Cancer Immunology Research. 10, 10, p. 1254-1262 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial

    Holmberg-Thydén, S., Dufva, I. H., Gang, Anne Ortved, Breinholt, M. F., Schejbel, L., Andersen, M. K., Kadivar, M., Svane, Inge Marie, Grønbæk, Kirsten, Hadrup, S. R. & El Fassi, D., 2022, In: Cancer Immunology, Immunotherapy. 71, p. 433-444

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. Published

    Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser

    Omland, S. H., Ejlertsen, J. S., Krustrup, D., Christensen, R. L., Svane, Inge Marie, Olesen, U. H. & Hædersdal, Merete, 2022, In: Cancers. 14, 23, 5815.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types

    Willumsen, N., Jensen, C., Green, G., Nissen, N. I., Neely, J., Nelson, D. M., Pedersen, R. S., Frederiksen, P., Chen, I. M., Boisen, M. K., Johansen, A. Z., Madsen, D. H., Svane, I. M., Lipton, A., Leitzel, K., Ali, S. M., Erler, J. T., Hurkmans, D. P., Mathijssen, R. H. J., Aerts, J. & 5 others, Eslam, M., George, J., Christiansen, C., Bissel, M. J. & Karsdal, M. A., 2022, In: Cellular and Molecular Life Sciences. 79, 4, 11 p., 204.

    Research output: Contribution to journalReviewResearchpeer-review

  42. Published

    Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy

    Chamberlain, C. A., Bennett, Eric Paul, Kverneland, Anders Handrup, Svane, Inge Marie, dqp123, dqp123 & Met, Özcan, 2022, In: Molecular Therapy - Oncolytics. 24, p. 417-428 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. Published

    Hud, blod og lymfesystem

    Hendel, Helle Westergren, Chakera, A. H., Svane, Inge Marie, Pedersen, Lars Møller, Oturai, P. S., Jensen, M. R. & Glenthøj, Andreas Birkedal, 2022, Klinisk Nuklearmedicin. Munksgaard , p. 187-220

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  44. Published

    Manufacture of adoptive cell therapies at academic cancer centers: scientific, safety and regulatory challenges

    Saini, K. S., Svane, Inge Marie, Juan, M., Barlesi, F. & André, F., 2022, In: Annals of Oncology. 33, 1, p. 6-12 7 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  45. Published

    Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma

    Kristensen, N. P., Heeke, C., Tvingsholm, S. A., Borch, A., Draghi, A., Crowther, M. D., Carri, I., Munk, K. K., Holm, J. S., Bjerregaard, A. M., Bentzen, A. K., Marquard, A. M., Szallasi, Z., McGranahan, N., Andersen, R., Nielsen, M., Jönsson, G. B., dqp123, dqp123, Svane, Inge Marie & Hadrup, S. R., 2022, In: Journal of Clinical Investigation. 132, 2, p. 1-16 150535.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment

    Bendtsen, S. K., Perez Penco, Maria, Hübbe, M. L., Martinenaite, E., Orebo Holmström, M., Weis-Banke, S. E., Grønne Dahlager Jørgensen, N., Jørgensen, M. A., Munir Ahmad, S., Jensen, K. M., Friese, C., Lundsager, M. T., Johansen, A. Z., Carretta, M., Ødum, Niels, Met, Özcan, Svane, Inge Marie, Madsen, Daniel Hargbøl & Andersen, Mads Hald, 2022, In: OncoImmunology. 11, 1, 2026020.

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021

    Ascierto, P. A., Avallone, A., Bhardwaj, N., Bifulco, C., Bracarda, S., Brody, J. D., Buonaguro, L., Demaria, S., Emens, L. A., Ferris, R. L., Galon, J., Khleif, S. N., Klebanoff, C. A., Laskowski, T., Melero, I., Paulos, C. M., Pignata, S., Ruella, M., Svane, I. M., Taube, J. M. & 3 others, Fox, B. A., Hwu, P. & Puzanov, I., 2022, In: Journal of Translational Medicine. 20, 1, 257.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Randomized Phase II Study of Nivolumab with or Without Ipilimumab Combined with Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)

    Chen, I. M., Johansen, Julia Sidenius, Theile, S., Hjaltelin, Jessica Xin, Novitski, Sif Ingibergsdóttir, Brunak, Søren, Hasselby, Jane Preuss, Willemoe, G. L., Lorentzen, T., Madsen, K., Jensen, B. V., Wilken, E. E., Geertsen, P., Behrens, C., Nolsøe, Christian, Hermann, K. L., Svane, Inge Marie & Nielsen, Dorte Lisbet, 2022, In: Journal of Clinical Oncology. 40, 27, p. 3180-3189

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Real-world data on melanoma brain metastases and survival outcome

    Pedersen, S., Møller, Søren, dqp123, dqp123, Persson, Gitte F., Svane, Inge Marie & Ellebaek, E., 2022, In: Melanoma Research. 32, 3, p. 173-182 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. Published

    Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis

    Dahl, E. K., Abed, O. K., Kjeldsen, J., dqp123, dqp123, Svane, Inge Marie, Dige, A., Agnholt, J. S., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, 2022, In: Alimentary Pharmacology and Therapeutics. 56, 9, p. 1370-1382 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. Published

    Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report

    Holmstroem, R. B., Dahl, E. K., Helms, Morten, Nielsen, H. V., Andersen, J. B., Bjerrum, Jakob Tveiten , Svane, Inge Marie, Ellebaek, E. & Seidelin, Jakob Benedict, 2022, In: BMJ Open Gastroenterology. 9, 1, 4 p., e000989.

    Research output: Contribution to journalJournal articleResearchpeer-review

  52. Published

    Transcriptomic signatures of tumors undergoing T cell attack

    Gokuldass, A., Schina, A., Lauss, M., Harbst, K., Chamberlain, C. A., Draghi, A., Westergaard, M. C. W., Nielsen, M., Papp, K., Sztupinszki, Z., Csabai, I., Svane, Inge Marie, Szallasi, Z., Jönsson, G. & dqp123, dqp123, 2022, In: Cancer Immunology, Immunotherapy. 71, 3, p. 553-563 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  53. Published

    Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

    Rohaan, M. W., Borch, T. H., Van Den Berg, J. H., Met, Ö., Kessels, R., Geukes Foppen, M. H., Stoltenborg Granhøj, J., Nuijen, B., Nijenhuis, C., Jedema, I., Van Zon, M., Scheij, S., Beijnen, J. H., Hansen, M., Voermans, C., Noringriis, I. M., Monberg, T. J., Holmstroem, R. B., Wever, L. D. V., Van Dijk, M. & 37 others, Grijpink-Ongering, L. G., Valkenet, L. H. M., Torres Acosta, A., Karger, M., Borgers, J. S. W., Ten Ham, R. M. T., Retèl, V. P., Van Harten, W. H., Lalezari, F., Van Tinteren, H., Van Der Veldt, A. A. M., Hospers, G. A. P., Stevense-Den Boer, M. A. M., Suijkerbuijk, K. P. M., Aarts, M. J. B., Piersma, D., Van Den Eertwegh, A. J. M., De Groot, J. W. B., Vreugdenhil, G., Kapiteijn, E., Boers-Sonderen, M. J., Fiets, W. E., Van Den Berkmortel, F. W. P. J., Ellebaek, E., Hølmich, Lisbet Rosenkrantz, Van Akkooi, A. C. J., Van Houdt, W. J., Wouters, M. W. J. M., Van Thienen, J. V., Blank, C. U., Meerveld-Eggink, A., Klobuch, S., Wilgenhof, S., Schumacher, T. N., dqp123, dqp123, Svane, Inge Marie & Haanen, J. B. A. G., 2022, In: New England Journal of Medicine. 387, 23, p. 2113-2125 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  54. Published

    Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions

    Granhøj, J. S., Jensen, Agnete Witness Præst, Presti, M., Met, Özcan, Svane, Inge Marie & dqp123, dqp123, 2022, In: Expert Opinion on Biological Therapy. 22, 5, p. 627-641 15 p.

    Research output: Contribution to journalReviewResearchpeer-review

  55. 2021
  56. Published

    Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition

    Kverneland, Anders Handrup, Borch, T. H., Granhøj, J., Sengeløv, Henrik, Donia, M. & Svane, Inge Marie, Aug 2021, In: Cytotherapy. 23, 8, p. 724-729 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  57. Published

    The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients

    Ellebaek, E., Svane, Inge Marie, Schmidt, H., Haslund, C. A., dqp123, dqp123, Hoejberg, L., Ruhlmann, C., Guldbrandt, L. M., Køhler, U. H. & Bastholt, L., Aug 2021, In: Cancer Epidemiology. 73, 7 p., 101943.

    Research output: Contribution to journalJournal articleResearchpeer-review

  58. Published

    Immune check point inhibitors are associated with a spectrum of cardiac events in patients with cancer

    D’souza, M., Svane, Inge Marie, Gislason, Gunnar Hilmar & Schou, Morten, 21 Apr 2021, In: European Heart Journal. 42, 16, p. 1636-1636 1 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  59. Published

    Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

    Araujo B. de Lima, V., Hansen, M., Spanggaard, I., Rohrberg, K., Reker Hadrup, S., Lassen, Ulrik Niels & Svane, Inge Marie, 25 Mar 2021, In: Frontiers in Oncology. 11, 11 p., 558248.

    Research output: Contribution to journalJournal articleResearchpeer-review

  60. Published

    Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

    Handlos Grauslund, J., Holmström, M. O., Jørgensen, N. G., Klausen, U., Weis-Banke, S. E., El Fassi, D., Schöllkopf, C., Clausen, M. B., Gjerdrum, L. M. R., Breinholt, M. F., Kjeldsen, J. W., Hansen, M., Koschmieder, S., Chatain, N., Novotny, G. W., Petersen, J., Kjær, L., Skov, V., Met, Ö., Svane, I. M. & 2 others, Hasselbalch, Hans Carl & Andersen, Mads Hald, 26 Feb 2021, In: Frontiers in Oncology. 11, 17 p., 637420.

    Research output: Contribution to journalJournal articleResearchpeer-review

  61. Published

    Cytotoxic T cells isolated from healthy donors and cancer patients kill TGFβ-expressing cancer cells in a TGFβ-dependent manner

    Holmström, M. O., Mortensen, R. E. J., Pavlidis, A. M., Martinenaite, E., Weis-Banke, S. E., Aaboe-Jørgensen, M., Bendtsen, S. K., Met, Özcan, Pedersen, A. W., Donia, M., Svane, Inge Marie & Andersen, Mads Hald, Feb 2021, In: Cellular and Molecular Immunology. 18, 2, p. 415-426 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  62. Published

    Neurologiske bivirkninger af cancerimmunterapi med checkpointinhibitorer

    Stenör, C., Ellebæk, E., El Mahdaoui, S. & Svane, Inge Marie, 11 Jan 2021, In: Ugeskrift for Laeger. 183, 2, 9 p., V05200406.

    Research output: Contribution to journalJournal articleResearchpeer-review

  63. Published

    A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

    Kjeldsen, J. W., Lorentzen, C. L., Martinenaite, E., Ellebaek, E., dqp123, dqp123, Holmstroem, R. B., Klausen, T. W., Madsen, C. O., Ahmed, S. M., Weis-Banke, S. E., Holmström, M. O., Hendel, Helle Westergren, Ehrnrooth, E., Zocca, M. B., Pedersen, A. W., Andersen, Mads Hald & Svane, Inge Marie, 2021, In: Nature Medicine. 27, p. pages2212–2223

    Research output: Contribution to journalJournal articleResearchpeer-review

  64. Published

    ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors

    Morgan Hulen , T., Chamberlain, C. A., Svane, Inge Marie & Met, Özcan, 2021, In: Immuno. 1, 3, p. 194-211

    Research output: Contribution to journalJournal articleResearchpeer-review

  65. Published

    An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma

    Klausen, U., Grønne Dahlager Jørgensen, N., Grauslund, J. H., Munir Ahmad, S., Gang, Anne Ortved, Martinenaite, E., Weis-Banke, S. E., Breinholt, M. F., Novotny, G. W., Kjeldsen, J. W., Orebo Holmström, M., Pedersen, L. B., Poulsen, C. B., Hansen, P. B., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2021, In: OncoImmunology. 10, 1, 1975889.

    Research output: Contribution to journalJournal articleResearchpeer-review

  66. Published

    Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma

    Borch, T. H., Harbst, K., Rana, A. H., Andersen, R., Martinenaite, E., Kongsted, P., Pedersen, M., Nielsen, M., Kjeldsen, J. W., Kverneland, Anders Handrup, Lauss, M., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Met, Özcan, Jönsson, G., dqp123, dqp123 & Svane, Inge Marie, 2021, In: Journal for ImmunoTherapy of Cancer. 9, 7, 15 p., e00270.

    Research output: Contribution to journalJournal articleResearchpeer-review

  67. Published

    Comparison of efficacy in patients with metastatic melanoma treated with ipilimumab and nivolumab who did or did not discontinue treatment due to immune-related adverse events: A real-world data study

    Fink, M., Vittrup, A. S., Bastholt, L., Svane, Inge Marie, dqp123, dqp123, Luczak, A. A., Ruhlmann, C. H., Guldbrandt, L. M., Koehler, U. H., Winther, M. L., Ellebaek, E., Haslund, C. A. & Schmidt, H., 2021, In: Cancers. 13, 21, 10 p., 5550.

    Research output: Contribution to journalJournal articleResearchpeer-review

  68. Published

    Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma

    Eggermont, A. M. M., Meshcheryakov, A., Atkinson, V., Blank, C. U., Mandala, M., Long, G. V., Barrow, C., Di Giacomo, A. M., Fisher, R., Sandhu, S., Kudchadkar, R., Romero, P. L. O., Svane, I. M., Larkin, J., Puig, S., Hersey, P., Quaglino, P., Queirolo, P., Stroyakovskiy, D., Bastholt, L. & 14 others, Mohr, P., Hernberg, M., Chiarion-Sileni, V., Strother, M., Hauschild, A., Yamazaki, N., van Akkooi, A. C., Lorigan, P., Krepler, C., Ibrahim, N., Marreaud, S., Kicinski, M., Suciu, S. & Robert, C., 2021, In: European Journal of Cancer. 158, p. 156-168 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  69. Published

    Laser immunotherapy: A potential treatment modality for keratinocyte carcinoma

    Omland, S. H., Wenande, E. C., Svane, Inge Marie, Tam, J., Olesen, U. H. & Hædersdal, Merete, 2021, In: Cancers. 13, 21, 18 p., 5405.

    Research output: Contribution to journalReviewResearchpeer-review

  70. Published

    Lynch syndrome-associated epithelial ovarian cancer and its immunological profile

    Rasmussen, M., Lim, K., Rambech, E., Andersen, Mads Hald, Svane, Inge Marie, Andersen, Ove, Jensen, L. H., Nilbert, Mef Christina & Therkildsen, C., 2021, In: Gynecologic Oncology. 162, 3, p. 686-693

    Research output: Contribution to journalJournal articleResearchpeer-review

  71. Published

    Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

    Duraiswamy, J., Turrini, R., Minasyan, A., Barras, D., Crespo, I., Grimm, A. J., Casado, J., Genolet, R., Benedetti, F., Wicky, A., Ioannidou, K., Castro, W., Neal, C., Moriot, A., Renaud-Tissot, S., Anstett, V., Fahr, N., Tanyi, J. L., Eiva, M. A., Jacobson, C. A. & 16 others, Montone, K. T., Westergaard, M. C. W., Svane, Inge Marie, Kandalaft, L. E., Delorenzi, M., Sorger, P. K., Färkkilä, A., Michielin, O., Zoete, V., Carmona, S. J., Foukas, P. G., Powell, D. J., Rusakiewicz, S., Doucey, M. A., Dangaj Laniti, D. & Coukos, G., 2021, In: Cancer Cell. 39, 12, p. 1623-1642.e20

    Research output: Contribution to journalJournal articleResearchpeer-review

  72. Published

    Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNϒ, Following Recognition of Autologous Tumor-Antigens

    Draghi, A., Chamberlain, C. A., Khan, S., Papp, K., Lauss, M., Soraggi, S., Radic, H. D., Presti, M., Harbst, K., Gokuldass, A., Kverneland, Anders Handrup, Nielsen, M., Westergaard, M. C. W., Andersen, Mads Hald, Csabai, I., Jönsson, G., Szallasi, Z., Svane, Inge Marie & dqp123, dqp123, 2021, In: Frontiers in Immunology. 12, 13 p., 705422.

    Research output: Contribution to journalJournal articleResearchpeer-review

  73. Published

    Real-time monitoring of mitochondrial respiration in cytokine-differentiated human primary T cells

    Mølgaard, K., Rahbech, A., Met, Özcan, Svane, Inge Marie, Straten, P., Desler, Claus & Peeters, M. J. W., 2021, In: Journal of Visualized Experiments. 176, e62984.

    Research output: Contribution to journalJournal articleResearchpeer-review

  74. Published

    The capacity of CD4+ Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56

    Holmen Olofsson, G., Pedersen, S. R., Aehnlich, P., Svane, Inge Marie, Idorn, M. & thor Straten, P., 2021, In: Cytotherapy. 23, 7, p. 582-589

    Research output: Contribution to journalJournal articleResearchpeer-review

  75. Published

    The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro

    Presti, M., Westergaard, M. C. W., Draghi, A., Chamberlain, C. A., Gokuldass, A., Svane, Inge Marie & dqp123, dqp123, 2021, In: Cancer Immunology, Immunotherapy. 70, p. 1771–1776

    Research output: Contribution to journalJournal articleResearchpeer-review

  76. Published

    The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study

    D’souza, M., Nielsen, Dorte Lisbet, Svane, Inge Marie, Iversen, Kasper, Rasmussen, P. V., Madelaire, C., Fosbøl, E., Køber, Lars Valeur, Gustafsson, Finn, Andersson, C., Gislason, Gunnar Hilmar, Torp-Pedersen, Christian & Schou, Morten, 2021, In: European Heart Journal. 42, 16, p. 1621-1631

    Research output: Contribution to journalJournal articleResearchpeer-review

  77. Published

    Vaccination against pd-l1 with io103 a novel immune modulatory vaccine in basal cell carcinoma: A phase iia study

    Jørgensen, N. G., Kaae, Jeanette, Grauslund, J. H., Met, Özcan, Nielsen, S. L., Pedersen, A. W., Svane, Inge Marie, Ehrnrooth, E., Andersen, Mads Hald, Zachariae, Claus & Skov, Lone, 2021, In: Cancers. 13, 4, p. 1-15 15 p., 911.

    Research output: Contribution to journalJournal articleResearchpeer-review

  78. 2020
  79. Published

    Escape from nonsense-mediated decay associates with anti-tumor immunogenicity

    Litchfield, K., Reading, J. L., Lim, E. L., Xu, H., Liu, P., Al-bakir, M., Wong, Y. N. S., Rowan, A., Funt, S. A., Merghoub, T., Perkins, D., Lauss, M., Svane, Inge Marie, Jönsson, G., Herrero, J., Larkin, J., Quezada, S. A., Hellmann, M. D., Turajlic, S. & Swanton, C., 1 Dec 2020, In: Nature Communications. 11, 1, 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  80. Published

    Cutaneous adverse reactions to anti–PD-1 treatment—A systematic review

    Simonsen, Anne Birgitte Nørremark, Kaae, Jeanette, Ellebaek, E., Svane, Inge Marie & Zachariae, Claus, 1 Nov 2020, In: Journal of the American Academy of Dermatology. 83, 5, p. 1415-1424 10 p.

    Research output: Contribution to journalReviewResearchpeer-review

  81. Published

    Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

    Araujo B de Lima, V., Borch, A., Hansen, M., Draghi, A., Spanggaard, I., Rohrberg, K., Reker Hadrup, S., Lassen, Ulrik Niels & Svane, Inge Marie, Apr 2020, In: Cytotherapy. 22, 4, p. 204-213 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  82. Published

    Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

    Kverneland, Anders Handrup, Pedersen, M., Wulff Westergaard, M. C., Nielsen, M., Borch, T. H., Olsen, L. R., Aasbjerg, G., Santegoets, S. J., van der Burg, S. H., Milne, K., Nelson, B. H., Met, Özcan, dqp123, dqp123 & Svane, Inge Marie, 2020, In: OncoTarget. 11, 22, p. 2092-2105 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  83. Published

    CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer

    Friese, C., Harbst, K., Borch, T. H., Westergaard, M. C. W., Pedersen, M., Kverneland, A., Jönsson, G., dqp123, dqp123, Svane, Inge Marie & Met, Özcan, 2020, In: Scientific Reports. 10, 1, 12 p., 3914.

    Research output: Contribution to journalJournal articleResearchpeer-review

  84. Published

    Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer

    Westergaard, M. C. W., Milne, K., Pedersen, M., Hasselager, T., Olsen, L. R., Anglesio, M. S., Borch, T. H., Kennedy, M., Briggs, G., Ledoux, S., Kreuzinger, C., Decken, I. V. D., Donia, M., Castillo-Tong, D. C., Nelson, B. H. & Svane, Inge Marie, 2020, In: Cancers. 12, 12, 19 p., 3828.

    Research output: Contribution to journalJournal articleResearchpeer-review

  85. Published

    Characterization of risk factors and efficacy of medical management of immune-related hepatotoxicity in real-world patients with metastatic melanoma treated with immune checkpoint inhibitors

    Romanski, N. A., Holmstroem, R. B., Ellebaek, E. & Svane, Inge Marie, 2020, In: European Journal of Cancer. 130, p. 211-218

    Research output: Contribution to journalJournal articleResearchpeer-review

  86. Published

    Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma

    Borch, T. H., Andersen, R., Ellebaek, E., Met, Özcan, dqp123, dqp123 & Svane, Inge Marie, 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, e000668.

    Research output: Contribution to journalJournal articleResearchpeer-review

  87. Published

    Genetic biomarkers in melanoma of the ocular region: What the medical oncologist should know

    Bol, K. F., dqp123, dqp123, Heegaard, Steffen, Kiilgaard, Jens Folke & Svane, Inge Marie, 2020, In: International Journal of Molecular Sciences . 21, 15, p. 1-14 14 p., 5231.

    Research output: Contribution to journalReviewResearchpeer-review

  88. Published

    Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

    Crowther, M. D., Dolton, G., Legut, M., Caillaud, M. E., Lloyd, A., Attaf, M., Galloway, S. A. E., Rius, C., Farrell, C. P., Szomolay, B., Ager, A., Parker, A. L., Fuller, A., dqp123, dqp123, McCluskey, J., Rossjohn, J., Svane, Inge Marie, Phillips, J. D. & Sewell, A. K., 2020, In: Nature Immunology. 21, 2, p. 178-185 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  89. Published

    Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade

    Jensen, C., Sinkeviciute, D., Madsen, D. H., Onnerfjord, P., Hansen, M., Schmidt, H., Karsdal, M. A., Svane, Inge Marie & Willumsen, N., 2020, In: Cancers. 12, 10, p. 1-15 2786.

    Research output: Contribution to journalJournal articleResearchpeer-review

  90. Published

    Improved progression-free long-term survival of a nation-wide patient population with metastatic melanoma

    Soerensen, A. V., Ellebaek, E., Bastholt, L., Schmidt, H., dqp123, dqp123 & Svane, Inge Marie, 2020, In: Cancers. 12, 9, p. 1-11 11 p., 2591.

    Research output: Contribution to journalJournal articleResearchpeer-review

  91. Published

    In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes

    Nielsen, M., Krarup-Hansen, Anders, Hovgaard, D., Petersen, Michael Mørk, Loya, Anand Chainsukh, Westergaard, M. C. W., Svane, Inge Marie & Junker, N., 2020, In: Cancer Immunology, Immunotherapy. 69, p. 2179-2191

    Research output: Contribution to journalJournal articleResearchpeer-review

  92. Published

    KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

    Ferrucci, P. F., Di Giacomo, A. M., Del Vecchio, M., Atkinson, V., Schmidt, H., Schachter, J., Queirolo, P., Long, G. V., Stephens, R., Svane, Inge Marie, Lotem, M., Abu-Amna, M., Gasal, E., Ghori, R., Diede, S. J., Croydon, E. S., Ribas, A., Ascierto, P. A. & KEYNOTE-022 international team, K. I. T., 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, 8 p., e001806.

    Research output: Contribution to journalJournal articleResearchpeer-review

  93. Published

    Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

    Ascierto, P. A., Del Vecchio, M., Mackiewicz, A., Robert, C., Chiarion-Sileni, V., Arance, A., Lebbé, C., Svane, I. M., Mcneil, C., Rutkowski, P., Loquai, C., Mortier, L., Hamid, O., Bastholt, L., Dreno, B., Schadendorf, D., Garbe, C., Nyakas, M., Grob, J. J., Thomas, L. & 10 others, Liszkay, G., Smylie, M., Hoeller, C., Ferraresi, V., Grange, F., Gutzmer, R., Pikiel, J., Hosein, F., Simsek, B. & Maio, M., 2020, In: Journal for ImmunoTherapy of Cancer. 8, 1, e000391.

    Research output: Contribution to journalJournal articleResearchpeer-review

  94. Published

    Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

    Jørgensen, N. G., Klausen, U., Grauslund, J. H., Helleberg, C., Aagaard, T. G., Do, T. H., Ahmad, S. M., Olsen, L. R., Klausen, T. W., Breinholt, M. F., Hansen, M., Martinenaite, E., Met, Özcan, Svane, Inge Marie, Knudsen, L. M. & Andersen, Mads Hald, 2020, In: Frontiers in Immunology. 11, 11 p., 595035.

    Research output: Contribution to journalJournal articleResearchpeer-review

  95. Published

    Qualitative analysis of tumor-infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8+ T cells in non-melanoma cancers compared to melanoma

    Gokuldass, A., Draghi, A., Papp, K., Borch, T. H., Nielsen, M., Westergaard, M. C. W., Andersen, R., Schina, A., Bol, K. F., Chamberlain, C. A., Presti, M., Met, Özcan, Harbst, K., Lauss, M., Soraggi, S., Csabai, I., Szállási, Z., Jönsson, G., Svane, Inge Marie & dqp123, dqp123, 2020, In: Cancers. 12, 11, p. 1-15 15 p., 3344.

    Research output: Contribution to journalJournal articleResearchpeer-review

  96. Published

    T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road

    Crowther, M. D., Svane, Inge Marie & Met, Özcan, 2020, In: Cells. 9, 7, 18 p., 1588.

    Research output: Contribution to journalReviewResearchpeer-review

  97. Published

    Tertiary lymphoid structures improve immunotherapy and survival in melanoma

    Cabrita, R., Lauss, M., Sanna, A., Donia, M., Skaarup Larsen, M., Mitra, S., Johansson, I., Phung, B., Harbst, K., Vallon-Christersson, J., van Schoiack, A., Lövgren, K., Warren, S., Jirström, K., Olsson, H., Pietras, K., Ingvar, C., Isaksson, K., Schadendorf, D., Schmidt, H. & 5 others, Bastholt, L., Carneiro, A., Wargo, J. A., Svane, Inge Marie & Jönsson, G., 2020, In: Nature. 577, p. 561-565

    Research output: Contribution to journalJournal articleResearchpeer-review

  98. Published

    The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

    Weis-Banke, S. E., Hübbe, M. L., Holmström, M. O., Jørgensen, M. A., Bendtsen, S. K., Martinenaite, E., Carretta, M., Svane, Inge Marie, Ødum, Niels, Pedersen, A. W., Met, Özcan, Madsen, D. H. & Andersen, Mads Hald, 2020, In: OncoImmunology. 9, 1, 16 p., 1771142.

    Research output: Contribution to journalJournal articleResearchpeer-review

  99. Published

    Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations

    Hansen, U. K., Ramskov, S., Bjerregaard, A. M., Borch, A., Andersen, R., Draghi, A., dqp123, dqp123, Bentzen, A. K., Marquard, A. M., Szallasi, Z., Eklund, A. C., Svane, Inge Marie & Hadrup, S. R., 2020, In: Frontiers in Immunology. 11, 373.

    Research output: Contribution to journalJournal articleResearchpeer-review

  100. 2019
  101. Published

    The real-world outcome of metastatic melanoma: Unknown primary vs. known cutaneous

    Ellebaek, E., Bastholt, L., Schmidt, H., Svane, Inge Marie & dqp123, dqp123, 1 Dec 2019, In: International Journal of Cancer. 145, 11, p. 3173-3174 2 p.

    Research output: Contribution to journalLetterResearchpeer-review

  102. Published

    Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma

    Bastholt, L., Schmidt, H., Bjerregaard, J. K., Herrstedt, Jørn & Svane, Inge Marie, Sep 2019, In: European journal of cancer (Oxford, England : 1990). 119, p. 122-131 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  103. Published

    High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort

    Bastholt, L., Svane, Inge Marie, Bjerregaard, J. K., Herrstedt, Jørn, Hróbjartsson, A. & Schmidt, H., Jul 2019, In: European journal of cancer (Oxford, England : 1990). 115, p. 61-67

    Research output: Contribution to journalJournal articleResearchpeer-review

  104. Published

    Principles of adoptive T cell therapy in cancer

    Met, Özcan, Jensen, K. M., Chamberlain, C. A., dqp123, dqp123 & Svane, Inge Marie, 11 Jan 2019, In: Seminars in Immunopathology. 41, 1, p. 49–58

    Research output: Contribution to journalJournal articleResearchpeer-review

  105. Published

    Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

    Martinenaite, E., Ahmad, S. M., Bendtsen, S. K., Jørgensen, M. A., Weis-Banke, S. E., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cancer Immunology, Immunotherapy. 68, 11, p. 1901-1907 7 p.

    Research output: Contribution to journalReviewResearchpeer-review

  106. Published

    Assessment of extracellular matrix and tissue derived metabolites in a liquid biopsy for identifying endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment.

    Willumsen, N., Bager, C. L., Jensen, C., Karsdal, M. A., Madsen, Daniel Hargbøl, Hansen, M., Schmidt, H. & Svane, Inge Marie, 2019, In: Journal of Clinical Oncology. 37, 15_suppl, e14050.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  107. Published

    B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment

    Sørensen, A. L., Bjørn, M. E., Riley, C. H., Holmstrøm, M., Andersen, Mads Hald, Svane, Inge Marie, Mikkelsen, S. U., Skov, V., Kjær, L., Hasselbalch, H. C. & Nielsen, C. H., 2019, In: European Journal of Haematology. 103, 4, p. 351-361 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  108. Published

    Cancerimmunterapi til behandling af hæmatologisk cancer

    Holmström, M. O., Klausen, U., Jørgensen, N. G., Holmberg, S., Grauslund, J., Met, Ö., Svane, Inge Marie, Pedersen, Lars Møller, Knudsen, L. M., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2019, In: Ugeskrift for Laeger. 181, 10, 5 p., V06180421.

    Research output: Contribution to journalJournal articleResearchpeer-review

  109. Published

    Chimeric antigen receptor-T-cellebehandling

    Muller, Klaus, Ifversen, M., Kielsen, K., Petersen, S. L., Met, Ö. & Svane, Inge Marie, 2019, In: Ugeskrift for Laeger. 181, 20A, 5 p., V05190309.

    Research output: Contribution to journalJournal articleResearchpeer-review

  110. Published

    Collagen density regulates the activity of tumor-infiltrating T cells

    Kuczek, D. E., Larsen, A. M. H., Thorseth, M., Carretta, M., Kalvisa, A., Siersbæk, M. S., Simões, A. M. C., Roslind, A., Engelholm, Lars Henning, Noessner, E., dqp123, dqp123, Svane, Inge Marie, Straten, P. T., Grøntved, L. & Madsen, D. H., 2019, In: Journal for ImmunoTherapy of Cancer. 7, 1, 15 p., 68.

    Research output: Contribution to journalJournal articleResearchpeer-review

  111. Published

    Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

    Ascierto, P. A., Ferrucci, P. F., Fisher, R., Del Vecchio, M., Atkinson, V., Schmidt, H., Schachter, J., Queirolo, P., Long, G. V., Di Giacomo, A. M., Svane, Inge Marie, Lotem, M., Bar-Sela, G., Couture, F., Mookerjee, B., Ghori, R., Ibrahim, N., Moreno, B. H. & Ribas, A., 2019, In: Nature Medicine. 25, 6, p. 941-946 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  112. Published

    Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs

    Draghi, A., Borch, T. H., Radic, H. D., Chamberlain, C. A., Gokuldass, A., Svane, Inge Marie & dqp123, dqp123, 2019, In: International Journal of Cancer. 145, 5, p. 1408-1413 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  113. Published

    Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

    Jansen, Y. J. L., Rozeman, E. A., Mason, R., Goldinger, S. M., Geukes Foppen, M. H., Højberg, L., Schmidt, H., van Thienen, J. V., Haanen, J. B. A. G., Tiainen, L., Svane, I. M., Mäkelä, S., Seremet, T., Arance, A., Dummer, R., Bastholt, L., Nyakas, M., Straume, O., Menzies, A. M., Long, G. V. & 3 others, Atkinson, V., Blank, C. U. & Neyns, B., 2019, In: Annals of Oncology. 30, 7, p. 1154-1161 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  114. Published

    Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis

    Dafni, U., Michielin, O., Lluesma, S. M., Tsourti, Z., Polydoropoulou, V., Karlis, D., Besser, M. J., Haanen, J., Svane, Inge Marie, Ohashi, P. S., Kammula, U. S., Orcurto, A., Zimmermann, S., Trueb, L., Klebanoff, C. A., Lotze, M. T., Kandalaft, L. E. & Coukos, G., 2019, In: Annals of Oncology. 30, 12, p. 1902-1913 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  115. Published

    Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells

    Saini, S. K., Tamhane, T., Anjanappa, R., Saikia, A., Ramskov, S., dqp123, dqp123, Svane, Inge Marie, Jakobsen, S. N., Garcia-Alai, M., Zacharias, M., Meijers, R., Springer, S. & Hadrup, S. R., 2019, In: Science immunology. 4, 37, eaau9039.

    Research output: Contribution to journalJournal articleResearchpeer-review

  116. Published

    Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

    Lebbé, C., Meyer, N., Mortier, L., Marquez-Rodas, I., Robert, C., Rutkowski, P., Menzies, A. M., Eigentler, T., Ascierto, P. A., Smylie, M., Schadendorf, D., Ajaz, M., Svane, Inge Marie, Gonzalez, R., Rollin, L., Lord-Bessen, J., Saci, A., Grigoryeva, E. & Pigozzo, J., 2019, In: Journal of Clinical Oncology. 37, 11, p. 867-875

    Research output: Contribution to journalJournal articleResearchpeer-review

  117. Published

    HER2 CAR-T cells eradicate uveal melanoma and T-cell therapy–resistant human melanoma in IL2 transgenic NOD/SCID IL2 receptor knockout mice

    Forsberg, E. M. V., Lindberg, M. F., Jespersen, H., Alsen, S., Bagge, R. O., dqp123, dqp123, Svane, Inge Marie, Nilsson, O., Ny, L., Nilsson, L. M. & Nilsson, J. A., 2019, In: Cancer Research. 79, 5, p. 899-904 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  118. Published

    High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

    Holmström, M. O., Ahmad, S. M., Klausen, U., Bendtsen, S. K., Martinenaite, E., Riley, C. H., Svane, Inge Marie, Kjær, L., Skov, V., Ellervik, Christina, Pallisgaard, N., Hasselbalch, H. C. & Andersen, Mads Hald, 2019, In: Blood Cancer Journal. 9, 2, 8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  119. Published

    Immunoprofiles of colorectal cancer from Lynch syndrome

    Walkowska, J., Kallemose, T., Jönsson, G., Jönsson, M., Andersen, Ove, Andersen, Mads Hald, Svane, Inge Marie, Langkilde, A., Nilbert, Mef Christina & Therkildsen, C., 2019, In: OncoImmunology. 8, 1, 9 p., e1515612.

    Research output: Contribution to journalJournal articleResearchpeer-review

  120. Published

    Immunterapi til patienter med malignt melanom og hjernemetastaser

    Simonsen, L. T., Schmidt, A. M. S., Øllegaard, T. H., Svane, Inge Marie, Bastholt, L., Luczak, A. A. & Schmidt, H., 2019, In: Ugeskrift for Laeger. 181, 24, 5 p., V01190057.

    Research output: Contribution to journalJournal articleResearchpeer-review

  121. Published

    Long-Term Exposure to Inflammation Induces Differential Cytokine Patterns and Apoptosis in Dendritic Cells

    Carstensen, L. S., Lie-Andersen, O., Obers, A., Crowther, M. D., Svane, Inge Marie & Hansen, M., 2019, In: Frontiers in Immunology. 10, 11 p., 2702.

    Research output: Contribution to journalJournal articleResearchpeer-review

  122. Published

    MERTK Acts as a costimulatory receptor on human cd8 t cells

    Peeters, M. J. W., Dulkeviciute, D., Draghi, A., Ritter, C., Rahbech, A., Skadborg, S. K., Seremet, T., Simoes, A. M. C., Martinenaite, E., Halldorsdottir, H. R., Andersen, Mads Hald, Olofsson, G. H., Svane, Inge Marie, Rasmussen, Lene Juel, Met, Özcan, Becker, J. C., dqp123, dqp123, Desler, Claus & Straten, P. T., 2019, In: Cancer Immunology Research. 7, 9, p. 1472-1484 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  123. Published

    Peptide Super-Agonist Enhances T-Cell Responses to Melanoma

    Galloway, S. A. E., Dolton, G., Attaf, M., Wall, A., Fuller, A., Rius, C., Bianchi, V., Theaker, S., Lloyd, A., Caillaud, M. E., Svane, Inge Marie, dqp123, dqp123, Cole, D. K., Szomolay, B., Rizkallah, P. & Sewell, A. K., 2019, In: Frontiers in Immunology. 10, 18 p., 319.

    Research output: Contribution to journalJournal articleResearchpeer-review

  124. Published

    Peripheral memory T cells specific for Arginase-1

    Martinenaite, E., Ahmad, S. M., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cellular and Molecular Immunology. 16, 8, p. 718-719 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  125. Published

    Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma

    Bol, K. F., Ellebaek, E., Hoejberg, L., Bagger, M. M., Larsen, M. S., Klausen, T. W., Køhler, U. H., Schmidt, H., Bastholt, L., Kiilgaard, Jens Folke, dqp123, dqp123 & Svane, Inge Marie, 2019, In: Cancers. 11, 10, 11 p., 1489;.

    Research output: Contribution to journalJournal articleResearchpeer-review

  126. Published

    Real-world evidence to guide healthcare policies in oncology

    dqp123, dqp123, Hansen, S. W. & Svane, Inge Marie, 2019, In: OncoTarget. 10, 44, p. 4513-4515

    Research output: Contribution to journalJournal articleResearchpeer-review

  127. Published

    Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

    Ascierto, P. A., Long, G. V., Robert, C., Brady, B., Dutriaux, C., Di Giacomo, A. M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., Savage, K. J., Hernberg, M. M., Lebbé, C., Charles, J., Mihalcioiu, C., Chiarion-Sileni, V., Mauch, C., Cognetti, F., Ny, L. & 8 others, Arance, A., Svane, Inge Marie, Schadendorf, D., Gogas, H., Saci, A., Jiang, J., Rizzo, J. & Atkinson, V., 2019, In: JAMA Oncology. 5, 2, p. 187-194

    Research output: Contribution to journalJournal articleResearchpeer-review

  128. Published

    T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients

    Viborg, N., Ramskov, S., Andersen, R. S., Sturm, T., Fugmann, T., Bentzen, A. K., Rafa, V. M., Straten, P. T., Svane, Inge Marie, Met, Özcan & Hadrup, S. R., 2019, In: OncoImmunology. 8, 12, 11 p., 1663107.

    Research output: Contribution to journalJournal articleResearchpeer-review

  129. Published

    The real-world impact of modern treatments on the survival of patients with metastatic melanoma

    dqp123, dqp123, Ellebaek, E., Øllegaard, T. H., Duval, L., Aaby, J. B., Hoejberg, L., Køhler, U. H., Schmidt, H., Bastholt, L. & Svane, Inge Marie, 2019, In: European Journal of Cancer. 108, p. 25-32 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  130. Published

    Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

    Westergaard, M. C. W., Andersen, R., Chong, C., Kjeldsen, J. W., Pedersen, M., Friese, C., Hasselager, T., Lajer, H., Coukos, G., Bassani-Sternberg, M., dqp123, dqp123 & Svane, Inge Marie, 2019, In: British Journal of Cancer. 120, p. 424-434

    Research output: Contribution to journalJournal articleResearchpeer-review

  131. 2018
  132. Published

    Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes

    Kjaer, L., Holmström, M. O., Cordua, S., Andersen, Mads Hald, Svane, Inge Marie, Thomassen, M., Kruse, T. A., Pallisgaard, N., Skov, V. & Hasselbalch, Hans Carl, Apr 2018, In: Leukemia and Lymphoma. 59, 4, p. 973-977 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  133. Published

    The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

    Holmstrom, M. O., Martinenaite, E., Ahmad, S. M., Met, Özcan, Friese, C., Kjaer, L., Riley, C. H., Straten, P. T., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 1 Feb 2018, In: Leukemia. 32, 2, p. 429-437

    Research output: Contribution to journalJournal articleResearchpeer-review

  134. Published

    Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

    Pedersen, M., Westergaard, M. C. W., Milne, K., Nielsen, M., Borch, T. H., Poulsen, L. G., Hendel, Helle Westergren, Kennedy, M., Briggs, G., Ledoux, S., Nøttrup, T. J., Andersen, P., Hasselager, T., Met, Ö., Nelson, B. H., dqp123, dqp123 & Svane, Inge Marie, 2018, In: OncoImmunology. 7, 12, 12 p., e1502905.

    Research output: Contribution to journalJournal articleResearchpeer-review

  135. Published

    Cancer immunotherapy in patients with brain metastases

    Caponnetto, S., Draghi, A., Borch, T. H., Nuti, M., Cortesi, E., Svane, Inge Marie & dqp123, dqp123, 2018, In: Cancer Immunology, Immunotherapy. 67, 5, p. 703-711 9 p.

    Research output: Contribution to journalReviewResearchpeer-review

  136. Published

    Cancerimmunterapi

    Kjeldsen, J. W., dqp123, dqp123 & Svane, Inge Marie, 2018, In: Ugeskrift for Laeger. 180, 5 p., V09170691.

    Research output: Contribution to journalJournal articleResearchpeer-review

  137. Published

    Checkpoint inhibitors in breast cancer - current status

    Polk, A., Svane, Inge Marie, Andersson, M. & Nielsen, Dorte Lisbet, 2018, In: Cancer Treatment Reviews. 63, p. 122-134

    Research output: Contribution to journalJournal articleResearchpeer-review

  138. Published

    Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab

    Kverneland, A. H., Enevold, C., dqp123, dqp123, Bastholt, L., Svane, Inge Marie & Nielsen, C. H., 2018, In: OncoImmunology. 7, 5, p. e1424674 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  139. Published

    Durable clinical responses and long-term follow-up of stage III-IV non-small-cell lung cancer (NSCLC) patients treated with IDO peptide vaccine in a phase i study-a brief research report

    Kjeldsen, J. W., Iversen, T. Z., Engell-Noerregaard, L., Mellemgaard, A., Andersen, Mads Hald & Svane, Inge Marie, 2018, In: Frontiers in Immunology. 9, SEP, 6 p., 2145.

    Research output: Contribution to journalJournal articleResearchpeer-review

  140. Published

    Frequent adaptive immune responses against arginase-1

    Martinenaite, E., Mortensen, R. E. J., Hansen, M., Orebo Holmström, M., Munir Ahmad, S., Grønne Dahlager Jørgensen, N., Met, Özcan, dqp123, dqp123, Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 3, 9 p., e1404215.

    Research output: Contribution to journalJournal articleResearchpeer-review

  141. Published

    Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients

    Jensen, C., Madsen, D. H., Hansen, M., Schmidt, H., Svane, Inge Marie, Karsdal, M. A. & Willumsen, N., 2018, In: Journal for ImmunoTherapy of Cancer. 6, 1, p. 1-10 10 p., 152.

    Research output: Contribution to journalJournal articleResearchpeer-review

  142. Published

    Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies

    Klausen, U., Holmberg, S., Holmstrom, M. O., Jorgensen, N. G. D., Grauslund, J. H., Svane, Inge Marie & Andersen, Mads Hald, 2018, In: Frontiers in Immunology. 9, 8 p., 2264.

    Research output: Contribution to journalReviewResearchpeer-review

  143. Published

    Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations

    Rius, C., Attaf, M., Tungatt, K., Bianchi, V., Legut, M., Bovay, A., dqp123, dqp123, Thor Straten, P., Peakman, M., Svane, Inge Marie, Ott, S., Connor, T., Szomolay, B., Dolton, G. & Sewell, A. K., 2018, In: The Journal of Immunology. 200, 7, p. 2263-2279

    Research output: Contribution to journalJournal articleResearchpeer-review

  144. Published

    Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response

    Holmström, M. O., Riley, C. H., Skov, V., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 6, e1433521.

    Research output: Contribution to journalJournal articleResearchpeer-review

  145. Published

    T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression

    Andersen, R., Borch, T. H., Draghi, A., Gokuldass, A., Rana, M. A. H., Pedersen, M., Nielsen, M., Kongsted, P., Kjeldsen, J. W., Westergaard, M. C. W., Radic, H. D., Chamberlain, C. A., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Larsen, M. S., Met, Özcan, Svane, Inge Marie & dqp123, dqp123, 2018, In: Annals of Oncology. 29, 7, p. 1575-1581 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  146. Published

    T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy

    Andersen, R., Westergaard, M. C. W., Kjeldsen, J. W., Müller, A., Pedersen, N. W., Hadrup, S. R., Met, Özcan, Seliger, B., Kromann-Andersen, B., Hasselager, T., dqp123, dqp123 & Svane, Inge Marie, 2018, In: Cancer Immunology Research. 6, 2, p. 222-235 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  147. Published

    The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

    Ahmad, S. M., Martinenaite, E., Holmström, M., Jørgensen, M. A., Met, Özcan, Nastasi, C., Klausen, U., dqp123, dqp123, Pedersen, Lars Møller, Munksgaard, Lars, Ødum, Niels, Woetmann, Anders , Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 2, 10 p., e1390641.

    Research output: Contribution to journalJournal articleResearchpeer-review

  148. 2017
  149. Published

    Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

    Donia, M., Harbst, K., van Buuren, M., Kvistborg, P., Lindberg, M. F., Andersen, R., Idorn, M., Munir Ahmad, S., Ellebæk, E., Mueller, A., Fagone, P., Nicoletti, F., Libra, M., Lauss, M., Hadrup, S. R., Schmidt, H., Andersen, M. H., Thor Straten, P., Nilsson, J. A., Schumacher, T. N. & 3 others, Seliger, B., Jönsson, G. & Svane, Inge Marie, 1 Sep 2017, In: Cancer Research. 77, 17, p. 4562-4566 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  150. Published

    Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

    Ascierto, P. A., Del Vecchio, M., Robert, C., Mackiewicz, A., Chiarion-Sileni, V., Arance, A., Lebbé, C., Bastholt, L., Hamid, O., Rutkowski, P., McNeil, C., Garbe, C., Loquai, C., Dreno, B., Thomas, L., Grob, J-J., Liszkay, G., Nyakas, M., Gutzmer, R., Pikiel, J. & 10 others, Grange, F., Hoeller, C., Ferraresi, V., Smylie, M., Schadendorf, D., Mortier, L., Svane, Inge Marie, Hennicken, D., Qureshi, A. & Maio, M., May 2017, In: Lancet Oncology. 18, 5, p. 611-622 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  151. Published

    Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study

    Kongsted, P., Borch, T. H., Ellebaek, E., Iversen, T. Z., Andersen, R., Met, Özcan, Hansen, M., Lindberg, H., Sengeløv, L. & Svane, Inge Marie, 1 Apr 2017, In: Cytotherapy. 19, 4, p. 500-513 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  152. Published

    Cancer immunotherapy in patients with preexisting autoimmune disorders

    dqp123, dqp123, Pedersen, M. & Svane, Inge Marie, Apr 2017, In: Seminars in Immunopathology. 39, 3, p. 333-337 5 p.

    Research output: Contribution to journalReviewResearchpeer-review

  153. Published

    Clinical Impact of the Number of Treatment Cycles in First-Line Docetaxel for Patients With Metastatic Castration-Resistant Prostate Cancer

    Kongsted, P., Svane, Inge Marie, Lindberg, H. & Sengeløv, L., Apr 2017, In: Clinical Genitourinary Cancer. 15, 2, p. e281-e287

    Research output: Contribution to journalJournal articleResearchpeer-review

  154. Published

    Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model

    Jespersen, H., Lindberg, M. F., dqp123, dqp123, Söderberg, E. M. V., Andersen, R., Keller, U., Ny, L., Svane, Inge Marie, Nilsson, L. M. & Nilsson, J. A., 2017, In: Nature Communications. 8, 10 p., 707.

    Research output: Contribution to journalJournal articleResearchpeer-review

  155. Published

    Immunterapi er kræftbehandling med en helt ny bivirkningsprofil

    Kondrup, M., Raunkilde, L., Svane, Inge Marie, Schmidt, H. & Bastholt, L., 2017, In: Ugeskrift for Laeger. 179, 5 p., V05170365.

    Research output: Contribution to journalJournal articleResearchpeer-review

  156. Published

    Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma

    Nitschke, N. J., Bjoern, J., Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, 2017, In: Stem Cell Investigation. 4, 13 p., 77.

    Research output: Contribution to journalJournal articleResearchpeer-review

  157. Published

    Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma

    Bjoern, J., Lyngaa, R., Andersen, R., Hølmich, Lisbet Rosenkrantz, Hadrup, S. R., dqp123, dqp123 & Svane, Inge Marie, 2017, In: OncoTarget. 8, 16, p. 27062-27074

    Research output: Contribution to journalJournal articleResearchpeer-review

  158. Published

    Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

    Lauss, M., dqp123, dqp123, Harbst, K., Andersen, R., Mitra, S., Rosengren, F., Salim, M., Vallon-Christersson, J., Törngren, T., Kvist, A., Ringnér, M., Svane, Inge Marie & Jönsson, G., 2017, In: Nature Communications. 8, 11 p., 1738.

    Research output: Contribution to journalJournal articleResearchpeer-review

  159. Published

    PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer

    dqp123, dqp123, Kjeldsen, J. W., Andersen, R., Westergaard, M. C. W., Bianchi, V., Legut, M., Attaf, M., Szomolay, B., Ott, S., Dolton, G., Lyngaa, R., Hadrup, S. R., Sewell, A. K. & Svane, Inge Marie, 2017, In: Clinical Cancer Research. 23, 19, p. 5779-5788

    Research output: Contribution to journalJournal articleResearchpeer-review

  160. Published

    PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy

    Steiniche, T., Vestergaard Danielsen, A., Wang, Z., Feng, Y., Switten Nielsen, P., Bastholt, L., Schmidt, H., Svane, Inge Marie, Dolled-Filhart, M., Emancipator, K., Weiner, R., Busch-Sørensen, M. & Zhou, W., 2017, In: Journal of the European Academy of Dermatology and Venereology. 31, 7, p. e319-e321

    Research output: Contribution to journalComment/debateResearch

  161. Published

    Predictors of responses to immune checkpoint blockade in advanced melanoma

    Jacquelot, N., Roberti, M. P., Enot, D. P., Rusakiewicz, S., Ternès, N., Jegou, S., Woods, D. M., Sodré, A. L., Hansen, M., Meirow, Y., Sade-Feldman, M., Burra, A., Kwek, S. S., Flament, C., Messaoudene, M., Duong, C. P. M., Chen, L., Kwon, B. S., Anderson, A. C., Kuchroo, V. K. & 30 others, Weide, B., Aubin, F., Borg, C., Dalle, S., Beatrix, O., Ayyoub, M., Balme, B., Tomasic, G., Di Giacomo, A. M., Maio, M., Schadendorf, D., Melero, I., Dréno, B., Khammari, A., Dummer, R., Levesque, M., Koguchi, Y., Fong, L., Lotem, M., Baniyash, M., Schmidt, H., Svane, Inge Marie, Kroemer, G., Marabelle, A., Michiels, S., Cavalcanti, A., Smyth, M. J., Weber, J. S., Eggermont, A. M. & Zitvogel, L., 2017, In: Nature Communications. 8, 13 p., 592.

    Research output: Contribution to journalJournal articleResearchpeer-review

  162. Published

    Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein

    Buschow, S. I., Ramazzotti, M., Reinieren-Beeren, I. M. J., Heinzerling, L. M., Westdorp, H., Stefanini, I., Beltrame, L., Hato, S. V., Ellebaek, E., Gross, S., Nguyen, V. A., Weinlich, G., Ragoussis, J., Baban, D., Schuler-Thurner, B., Svane, I. M., Romani, N., Austyn, J. M., De Vries, I. J. M., Schuler, G. & 2 others, Cavalieri, D. & Figdor, C. G., 2017, In: OncoTarget. 8, 40, p. 67439-67456 18 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  163. Published

    The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

    Holmström, M. O., Hjortso, M. D., Ahmad, S. M., Met, Özcan, Martinenaite, E., Riley, C., Straten, P., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2017, In: Leukemia. 31, p. 495-498

    Research output: Contribution to journalLetterResearchpeer-review

  164. Published

    The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials

    dqp123, dqp123, Kimper-Karl, M. L., Høyer, K. L., Bastholt, L., Schmidt, H. & Svane, Inge Marie, 2017, In: European Journal of Cancer. 74, p. 89-95

    Research output: Contribution to journalJournal articleResearchpeer-review

  165. 2016
  166. Published

    Isolated asymptomatic masseter muscle metastasis as first sign of metastatic disease in a patient with known melanoma

    Gjorup, C. A., Hendel, Helle Westergren, Svane, Inge Marie & Hølmich, Lisbet Rosenkrantz, 1 Dec 2016, In: J P R A S Open. 10, p. 1-4 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  167. Published

    The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

    Holmström, M. O., Riley, C. H., Svane, Inge Marie, Hasselbalch, H. C. & Andersen, Mads Hald, Dec 2016, In: Leukemia. 30, 12, p. 2413-2416 14 p.

    Research output: Contribution to journalLetterResearchpeer-review

  168. Published

    The Danish Melanoma Database

    Hølmich, Lisbet Rosenkrantz, Klausen, S., Spaun, E., Schmidt, G., Gad, D., Svane, Inge Marie, Schmidt, H., Lorentzen, H. F. & Ibfelt, E. H., 25 Oct 2016, In: Clinical Epidemiology. 8, p. 543-548 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  169. Published

    Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes

    Bentzen, A. K., Marquard, A. M., Lyngaa, R., Saini, S. K., Ramskov, S., Donia, M., Such, L., Furness, A. J. S., McGranahan, N., Rosenthal, R., thor Straten, E. P., Szallasi, Z., Svane, Inge Marie, Swanton, C., Quezada, S. A., Jakobsen, S. N., Eklund, A. C. & Hadrup, S. R., Oct 2016, In: Nature Biotechnology. 34, 10, p. 1037-1045 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  170. Published

    Therapeutic Vaccination against A Modified Minimal Survivin Epitope Induces Functional CD4 T Cells That Recognize Survivin-Expressing Cells

    Nitschke, N. J., Bjoern, J., Met, Özcan, Svane, Inge Marie & Andersen, M. H., 1 Sep 2016, In: Scandinavian Journal of Immunology. 84, 3, p. 191-193 3 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  171. Published

    mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma

    Borch, T. H., Engell-Noerregaard, L., Iversen, T. Z., Ellebaek, E., Met, Özcan, Hansen, M., Andersen, Mads Hald, thor Straten, E. P. & Svane, Inge Marie, 1 Sep 2016, In: OncoImmunology. 5, 9, 12 p., e1207842.

    Research output: Contribution to journalJournal articleResearchpeer-review

  172. Published

    Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21

    Hansen, M., Met, Özcan, Larsen, N. B., Rosenkilde, Mette, Andersen, Mads Hald, Svane, Inge Marie & Hjortø, Gertrud Malene, Sep 2016, In: Cytotherapy. 18, 9, p. 1187-1196

    Research output: Contribution to journalJournal articleResearchpeer-review

  173. Published

    PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine

    Munir Ahmad, S., Martinenaite, E., Hansen, M., Junker, N., Borch, T. H., Met, Özcan, Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2 Aug 2016, In: OncoImmunology. 5, 8, e1202391.

    Research output: Contribution to journalJournal articleResearchpeer-review

  174. Published

    Cabazitaxel as second-line or third-line therapy in patients with metastatic castration-resistant prostate cancer

    Kongsted, P., Svane, Inge Marie, Lindberg, H., Bisbjerg, R., Daugaard, G. & Sengeløv, L., Aug 2016, In: Anti-Cancer Drugs. 27, 7, p. 695-701 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  175. Published

    Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

    Andersen, R., Donia, M., Ellebæk, E., Borch, T. H., Kongsted, P., Iversen, T. Z., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Met, Özcan, Andersen, Mads Hald, Thor Straten, E. P. & Svane, Inge Marie, Aug 2016, In: Clinical Cancer Research. 22, 15, p. 3734-3745 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  176. Published

    Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab

    Bjørn, J., Iversen, T. Z., Nitschke, N. J., Andersen, Mads Hald & Svane, Inge Marie, Aug 2016, In: Cytotherapy. 18, 8, p. 1043-1055 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  177. Published

    Behandlingen af BRAF-muteret metastatisk melanom med BRAF/MEK-inhibitorer bedrer prognosen

    Boyles, T. B., Svane, Inge Marie, Bastholt, L. & Schmidt, H., 2016, In: Ugeskrift for Laeger. 178, 4 p., V02160126.

    Research output: Contribution to journalJournal articleResearchpeer-review

  178. Published

    CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

    Martinenaite, E., Munir Ahmad, S., Hansen, M., Met, Özcan, Westergaard, M. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2016, In: OncoImmunology. 5, 11, 10 p., e1238541.

    Research output: Contribution to journalJournal articleResearchpeer-review

  179. Published

    Immuncheckpointantistoffer øger overlevelsen for patienter med metastatisk melanom

    Fløe, L. E., Svane, Inge Marie, Bastholt, L. & Schmidt, H., 2016, In: Ugeskrift for Laeger. 178, 4 p., V01160070.

    Research output: Contribution to journalJournal articleResearchpeer-review

  180. Published

    Immune monitoring using mRNA-transfected dendritic cells

    Borch, T. H., Svane, Inge Marie & Met, Özcan, 2016, Synthetic mRNA: Production, Introduction Into Cells, and Physiological Consequences. Humana Press, Vol. 1428. p. 245-259 15 p. (Methods in Molecular Biology, Vol. 1428).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  181. Published

    Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab

    Bjoern, J., Juul Nitschke, N., Zeeberg Iversen, T., Schmidt, H., Fode, K. & Svane, Inge Marie, 2016, In: OncoImmunology. 5, 4, 10 p., e1100788.

    Research output: Contribution to journalJournal articleResearchpeer-review

  182. Published

    Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera

    Riley, C. H., Brimnes, M. K., Hansen, M., Jensen, M. K., Hasselbalch, Hans Carl, Kjaer, L., Straten, P. T. & Svane, Inge Marie, 2016, In: European Journal of Haematology. 97, 1, p. 83-92 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  183. Published

    Large-scale mRNA transfection of dendritic cells by electroporation in continuous flow systems

    Selmeczi, D., Hansen, T. S., Met, Özcan, Svane, Inge Marie & Larsen, N. B., 2016, Methods in Molecular Biology. Humana Press, Vol. 1428. p. 151-161 11 p. (Methods in Molecular Biology, Vol. 1428).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  184. Published

    Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

    Jørgensen, N. G., Ahmad, S. M., Abildgaard, N., Straten, P. T., Svane, Inge Marie, Andersen, Mads Hald & Knudsen, L. M., 2016, In: Stem Cell Investigation. 3, 5 p., 95.

    Research output: Contribution to journalJournal articleResearchpeer-review

  185. Published

    Predictors of Chemotherapy-Induced Toxicity and Treatment Outcomes in Elderly Versus Younger Patients With Metastatic Castration-Resistant Prostate Cancer

    Kongsted, P., Svane, Inge Marie, Lindberg, H. & Sengeløv, L., 2016, In: Clinical Genitourinary Cancer. 14, 6, p. e559-e568

    Research output: Contribution to journalJournal articleResearchpeer-review

  186. Published

    The controversial role of TNF in melanoma

    Donia, M., Kjeldsen, J. W. & Svane, Inge Marie, 2016, In: OncoImmunology. 5, 4, 2 p., e1107699.

    Research output: Contribution to journalComment/debateResearchpeer-review

  187. Published

    Transfection of tumor-infiltrating T cells with mRNA encoding CXCR2

    Idorn, M., thor Straten, E. P., Svane, Inge Marie & Met, Özcan, 2016, Synthetic mRNA: Production, Introduction Into Cells, and Physiological Consequences. Rhoads, R. E. (ed.). Springer, Vol. 1428. p. 261-276 16 p. (Methods in Molecular Biology, Vol. 1428).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  188. 2015
  189. Published

    Tumor-infiltrating lymphocytes for the treatment of metastatic cancer

    Geukes Foppen, M. H., Donia, M., Svane, Inge Marie & Haanen, J. B. A. G., Dec 2015, In: Molecular Oncology. 9, 10, p. 1918-35 18 p.

    Research output: Contribution to journalReviewResearchpeer-review

  190. Published

    Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?

    Kongsted, P., Svane, Inge Marie, Lindberg, H., Daugaard, G. & Sengeløv, L., Nov 2015, In: Urologic Oncology: Seminars and Original Investigations. 33, 11, p. 494.e15-20

    Research output: Contribution to journalJournal articleResearchpeer-review

  191. Published

    Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05

    Frøsig, T. M., Yap, J., Seremet, T., Lyngaa, R., Svane, Inge Marie, Thor Straten, P., Heemskerk, M. H. M., Grotenbreg, G. M. & Hadrup, S. R., Oct 2015, In: Cytometry. Part A. 87, 10, p. 967-75 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  192. Published

    Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity

    Donia, M., Andersen, R., Kjeldsen, J. W., Fagone, P., Munir, S., Nicoletti, F., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 15 Sep 2015, In: Cancer Research. 75, 18, p. 3747-59 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  193. Published

    More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers

    Dolton, G., Tungatt, K., Lloyd, A., Bianchi, V., Theaker, S. M., Trimby, A., Holland, C. J., Donia, M., Godkin, A. J., Cole, D. K., Straten, P. T., Peakman, M., Svane, Inge Marie & Sewell, A. K., Sep 2015, In: Immunology. 146, 1, p. 11-22 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  194. Published

    Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies

    Borch, T. H., Donia, M., Andersen, Mads Hald & Svane, Inge Marie, Sep 2015, In: Drug Discovery Today. 20, 9, p. 1127-34 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  195. Published

    Broadening the repertoire of melanoma-associated T-cell epitopes

    Frøsig, T. M., Lyngaa, R., Met, Özcan, Larsen, S. K., Donia, M., Svane, Inge Marie, Thor Straten, P. & Hadrup, S. R., May 2015, In: Cancer immunology, immunotherapy : CII. 64, 5, p. 609-20 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  196. Published

    Neuroprotective and anti-inflammatory mechanisms are activated early in optic neuritis

    Tsakiri, A., Ravanidis, S., Lagoudaki, R., Poulatsidou, K., Svane, Inge Marie, Fredriksen, Jette Lautrup & Grigoriadis, N., May 2015, In: Acta Neurologica Scandinavica. 131, 5, p. 305-12 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  197. Published

    Confinement dependent chemotaxis in two-photon polymerized linear migration constructs with highly definable concentration gradients

    Hjortø, Gertrud Malene, Olsen, M. H., Svane, Inge Marie & Larsen, N. B., Apr 2015, In: Biomedical Microdevices. 17, 2, p. 1-10 10 p., 30.

    Research output: Contribution to journalJournal articleResearchpeer-review

  198. Published

    Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

    Weber, J. S., D'Angelo, S. P., Minor, D., Hodi, F. S., Gutzmer, R., Neyns, B., Hoeller, C., Khushalani, N. I., Miller, W. H., Lao, C. D., Linette, G. P., Thomas, L., Lorigan, P., Grossmann, K. F., Hassel, J. C., Maio, M., Sznol, M., Ascierto, P. A., Mohr, P., Chmielowski, B. & 8 others, Bryce, A., Svane, Inge Marie, Grob, J., Krackhardt, A. M., Horak, C., Lambert, A., Yang, A. S. & Larkin, J., Apr 2015, In: Lancet Oncology. 16, 4, p. 375-84 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  199. Published

    Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α

    Riley, C. H., Hansen, M., Brimnes, M. K., Hasselbalch, H. C., Bjerrum, O. W., Straten, P. T., Svane, Inge Marie & Jensen, M. K., Mar 2015, In: European Journal of Haematology. 94, 3, p. 227–234 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  200. Published

    Antibody Stabilization of Peptide–MHC Multimers Reveals Functional T Cells Bearing Extremely Low-Affinity TCRs

    Tungatt, K., Bianchi, V., Crowther, M. D., Powell, W. E., Schauenburg, A. J., Trimby, A., Donia, M., Miles, J. J., Holland, C. J., Cole, D. K., Godkin, A. J., Peakman, M., Straten, P. T., Svane, Inge Marie, Sewell, A. K. & Dolton, G., Jan 2015, In: Journal of immunology (Baltimore, Md. : 1950). 194, 1, p. 463-474 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  201. Published

    The Targeting of Indoleamine 2,3 Dioxygenase -Mediated Immune Escape in Cancer

    Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, Jan 2015, In: Basic & Clinical Pharmacology & Toxicology. 116, 1, p. 19-24 6 p.

    Research output: Contribution to journalReviewResearchpeer-review

  202. Published

    Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

    Hjortsø, M. D., Larsen, S. K., Kongsted, P., Met, Özcan, Frøsig, T. M., Andersen, G. H., Ahmad, S. M., Svane, Inge Marie, Becker, J. C., Straten, P. T. & Andersen, Mads Hald, Jan 2015, In: OncoImmunology. 4, 1, e968480.

    Research output: Contribution to journalJournal articleResearchpeer-review

  203. Published

    Indoleamine 2,3-dioxygenase vaccination

    Andersen, Mads Hald & Svane, Inge Marie, 2015, In: OncoImmunology. 4, 1, p. 1-3 3 p., e983770.

    Research output: Contribution to journalJournal articleResearchpeer-review

  204. Published

    Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma

    Andersen, R., Donia, M., Westergaard, M. C. W., Pedersen, M., Hansen, M. & Svane, Inge Marie, 2015, In: Human Vaccines & Immunotherapeutics. 11, 12, p. 2790-5 6 p.

    Research output: Contribution to journalComment/debateResearch

  205. 2014
  206. Published

    Successful treatment with Ipilimumab and Interleukin‑2 in two patients with metastatic melanoma and systemic autoimmune disease

    Pedersen, M., Andersen, R., Larsen, P. N., Jacobsen, Søren, Thielsen, P., Thor Straten, P. & Svane, Inge Marie, Dec 2014, In: Cancer immunology, immunotherapy : CII. 63, 12, p. 1341-6 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  207. Published

    Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor

    Donia, M., Larsen, S. M., Met, Özcan & Svane, Inge Marie, Aug 2014, In: Cytotherapy. 16, 8, p. 1117–1120 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  208. Published

    Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab

    Andersen, R., Nørgaard, P. H., Al-Jailawi, M. K. M. & Svane, Inge Marie, 23 Jan 2014, In: OncoImmunology. 3, 8, e954506.

    Research output: Contribution to journalJournal articleResearchpeer-review

  209. Published

    Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase

    Iversen, T. Z., Engell-Noerregaard, L., Ellebaek, E., Andersen, R. S., Larsen, S. K., Bjoern, J., Zeyher, C., Gouttefangeas, C., Thomsen, B. M., Holm, B., Thor Straten, P., Mellemgaard, A., Andersen, Mads Hald & Svane, Inge Marie, 1 Jan 2014, In: Clinical Cancer Research. 20, 1, p. 221-232 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  210. Published

    Spontaneous presence of FOXO3-specific T cells in cancer patients

    Larsen, S. K., Ahmad, S. M., Idorn, M., Met, Özcan, Martinenaite, E., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 1 Jan 2014, In: OncoImmunology. 3, 8, e953411.

    Research output: Contribution to journalJournal articleResearchpeer-review

  211. Published

    Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway

    Ahmad, S. M., Larsen, S. K., Svane, Inge Marie & Andersen, M. H., Jan 2014, In: Leukemia. 28, 1, p. 236-238 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  212. Published

    Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?

    Svane, Inge Marie & Verdegaal, E. M., 2014, In: Cancer immunology, immunotherapy : CII. 63, 10, p. 1081-1091 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  213. 2013
  214. Published

    In-chip fabrication of free-form 3D constructs for directed cell migration analysis

    Olsen, M. H., Hjortø, Gertrud Malene, Hansen, M., Met, Özcan, Svane, Inge Marie & Larsen, N. B., 21 Dec 2013, In: Lab On a Chip. 13, 24, p. 4800-4809 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  215. Published

    Functional characterization of Foxp3-specific spontaneous immune responses

    Larsen, S. K., Munir, S., Woetmann, Anders , Frøsig, T. M., Ødum, Niels, Svane, Inge Marie, Becker, J. C. & Andersen, Mads Hald, Dec 2013, In: Leukemia. 27, 12, p. 2332-40 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  216. Published

    HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

    Munir, S., Andersen, G. H., Met, Özcan, Donia, M., Frøsig, T. M., Larsen, S. K., Klausen, T. W., Svane, Inge Marie & Andersen, Mads Hald, 15 Mar 2013, In: Cancer Research. 73, 6, p. 1764-76 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  217. Published

    Analysis of Survivin-Specific T Cells in Breast Cancer Patients Using Human DCs Engineered with Survivin mRNA

    Met, Özcan & Svane, Inge Marie, 2013, Synthetic Messenger RNA and Cell Metabolism Modulation. Vol. 969. p. 275-292 18 p. (Methods in Molecular Biology).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  218. Published

    Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy

    Hansen, M., Hjortø, Gertrud Malene, Donia, M., Met, Özcan, Larsen, N. B., Andersen, M. H., Thor Straten, P. & Svane, Inge Marie, 2013, In: Vaccine. 31, 4, p. 639-46 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  219. Published

    Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients

    Iversen, T. Z., Brimnes, M. K., Nikolajsen, K., Andersen, R. S., Hadrup, S. R., Andersen, M. H., Bastholt, L. & Svane, Inge Marie, 2013, In: OncoImmunology. 2, 2, p. 1-10 10 p., e23288.

    Research output: Contribution to journalJournal articleResearchpeer-review

  220. Published

    FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma

    Engell-Noerregaard, L., Hendel, H. W., Johannesen, H. H., Alslev, L. & Svane, Inge Marie, 2013, In: Cancer Immunology, Immunotherapy. 62, 1, p. 17-25 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  221. Published

    Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion

    Donia, M., Hansen, M., Sendrup, S. L., Iversen, T. Z., Ellebæk, E., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2013, In: Journal of Investigative Dermatology. 133, 2, p. 545-52 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  222. Published

    Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells

    Cathelin, D., Met, Özcan & Svane, Inge Marie, 2013, In: Cytotherapy. 15, 6, p. 740-749 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  223. Published

    The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells

    Munir, S., Andersen, G. H., Svane, Inge Marie & Andersen, Mads Hald, 2013, In: OncoImmunology. 2, 4, 9 p., e23991.

    Research output: Contribution to journalJournal articleResearchpeer-review

  224. 2012
  225. Published

    A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type alleles

    Junker, N., Munir, S., Kvistborg, P., Straten, P. T., Svane, Inge Marie & Andersen, M. H., 2012, In: Journal of Investigative Dermatology. 132, 8, p. 2115-2118 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  226. Published

    Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

    Ellebaek, E., Iversen, T. Z., Junker, N., Donia, M., Engell-Noerregaard, L., Met, Özcan, Hølmich, Lisbet Rosenkrantz, Andersen, R. S., Hadrup, S. R., Andersen, M. H., Thor Straten, P. & Svane, Inge Marie, 2012, In: Journal of Translational Medicine. 10, p. 169

    Research output: Contribution to journalJournal articleResearchpeer-review

  227. Published

    Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

    Donia, M., Ellebaek, E., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2012, In: OncoImmunology. 1, 8, p. 1297-1304 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  228. Published

    BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

    Donia, M., Fagone, P., Nicoletti, F., Andersen, R. S., Høgdall, E., Straten, P. T., Andersen, M. H. & Svane, Inge Marie, 2012, In: OncoImmunology. 1, 9, p. 1476-1483 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  229. Published

    Cellular based cancer vaccines: type 1 polarization of dendritic cells

    Hansen, M., Met, O., Svane, Inge Marie & Andersen, M. H., 2012, In: Current Medicinal Chemistry. 19, 25, p. 4239-46 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  230. Published

    Cellular based cancer vaccines: type 1 polarization of dendritic cells

    Hansen, M., Met, Özcan, Svane, Inge Marie & Andersen, M. H., 2012, In: Current Medicinal Chemistry. 19, 25, p. 4239-46 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  231. Published

    Characterization and comparison of "Standard" and "Young" tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational Research Institution

    Donia, M., Junker, N., Ellebaek, E., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2012, In: Scandinavian Journal of Immunology. 75, 2, p. 157-167 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  232. Published

    Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

    Svane, Inge Marie, Straten, P. T., Andersen, M. H., Larsen, S. K. & Hansen, M., 2012, In: Cells. 1, 2, p. 51-60 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  233. Published

    Characterization of T-cell responses against IκBα in cancer patients

    Munir, S., Frøsig, T. M., Hansen, M., Svane, Inge Marie & Andersen, M. H., 2012, In: OncoImmunology. 1, 8, p. 1290-1296 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  234. Published

    Comment on "Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy" by Gustav J. Ullenhag et al

    Svane, Inge Marie, 2012, In: Cancer Immunology, Immunotherapy. 61, 5, p. 747; author reply 749

    Research output: Contribution to journalJournal articleResearchpeer-review

  235. Published

    Dissection of T-cell antigen specificity in human melanoma

    Andersen, R. S., Albæk Thrue, C., Junker, N., Skou, R. B. L., Donia, M., Ellebæk, E., Svane, Inge Marie, Schumacher, T. N., Thor Straten, P. & Hadrup, S. R., 2012, In: Cancer Research. 72, 7, p. 1642-50 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  236. Published

    Effector and regulatory T cells in patients with acute optic neuritis

    Tsakiri, A., Kjærsgaard, E., Grigoriadis, N., Svane, Inge Marie & Frederiksen, J. L., 2012, In: Neuroimmunomodulation. 19, 2, p. 111-20 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  237. Published

    Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion

    Brimnes, M. K., Gang, A. O., Donia, M., Thor Straten, P., Svane, Inge Marie & Hadrup, S. R., 2012, In: Cancer Immunology, Immunotherapy. 61, 8, p. 1221-31 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  238. Published

    IFN-γ to improve immunotherapy for melanoma

    Donia, M., Svane, Inge Marie, Andersen, M. H., Hansen, M., Straten, P. T., Ellebæk, E., Iversen, T. Z. & SL, S., 2012. 0 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  239. Published

    Immunotherapy for metastatic colorectal cancer: Present status and new options

    Ellebaek, E., Andersen, M. H., Svane, Inge Marie & Straten, P. T., 2012, In: Scandinavian Journal of Gastroenterology. 47, 3, p. 315-24 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  240. Published

    Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

    Ellebaek, E., Engell-Noerregaard, L., Iversen, T. Z., Moerch Froesig, T., Munir, S., Hadrup, S. R., Andersen, M. H. & Svane, Inge Marie, 2012, In: Cancer Immunology, Immunotherapy. 61, 10, p. 1791-1804 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  241. Published

    Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase

    Munir, S., Larsen, S. K., Iversen, T. Z., Donia, M., Klausen, T. W., Svane, Inge Marie, Straten, P. T. & Andersen, M. H., 2012, In: P L o S One. 7, 4, p. e34568

    Research output: Contribution to journalJournal articleResearchpeer-review

  242. Published

    Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures

    Junker, N., Kvistborg, P., Køllgaard, T., Straten, P. T., Andersen, Mads Hald & Svane, Inge Marie, 2012, In: Cellular Immunology. 273, 1, p. 1-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  243. 2011
  244. Published

    Increase in circulating CD4CD25Foxp3 T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

    Riley, C. H., Morten Krogh, J., Brimnes, M. K., Straten, P. T., Svane, Inge Marie, Hasselbalch, Hans Carl & Bjerrum, O. W., 25 Aug 2011, In: Blood. 118, 8, p. 2170-2173 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  245. Published

    Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip

    Selmeczi, D., Hansen, T. S., Met, Özcan, Svane, Inge Marie & Larsen, N. B., Apr 2011, In: Biomedical Microdevices. 13, 2, p. 383-92 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  246. Published

    Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

    Junker, N., Andersen, Mads Hald, Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., Buchwald, C. V., Andersen, E., Straten, P. T., Svane, Inge Marie & Andersen, Mads Hald, 24 Mar 2011, In: Cytotherapy. 13, 7, p. 822-34

    Research output: Contribution to journalJournal articleResearchpeer-review

  247. Published

    Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2

    Sørensen, R. B., Køllgaard, T., Andersen, R. S., van den Berg, J. H., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 15 Mar 2011, In: Cancer Research. 71, 6, p. 2038-44 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  248. Published

    Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

    Sørensen, R. B., Hadrup, S. R., Svane, Inge Marie, Hjortsø, M. C., Thor Straten, P., Andersen, Mads Hald, Hjortsø, M. C. & Andersen, Mads Hald, 17 Feb 2011, In: Blood. 117, 7, p. 2200-10 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  249. Published

    Cell culture plastics with immobilized interleukin-4 for monocyte differentiation

    Hansen, M., Hjortø, Gertrud Malene, Met, Özcan, Jakobsen, M. H., Svane, Inge Marie & Larsen, N. B., Feb 2011, In: Journal of Biomedical Materials Research. Part A. 96, 2, p. 372-83 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  250. Published

    High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer

    Met, Özcan, Balslev, E., Flyger, H. & Svane, Inge Marie, 1 Jan 2011, In: Breast Cancer Research and Treatment. 125, 2, p. 395-406 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  251. Published

    Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

    Junker, N., Andersen, Mads Hald, Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., von Buchwald, Christian, Andersen, E., Straten, P. T. & Svane, Inge Marie, 2011, In: Cytotherapy. 13, 7, p. 822-34 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  252. Published

    Cell culture plastics with immobilized interleukin-4 for monocyte differentiation

    Hansen, M., Hjortø, Gertrud Malene, Met, Ö., Jakobsen, M. H., Svane, Inge Marie & Larsen, N., 2011, In: Journal of Biomedical Materials Research. Part A. 96, 2, p. 372-83 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  253. Published

    Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2

    Bjoern, J., Brimnes, M. K., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2011, In: Scandinavian Journal of Immunology. 73, 3, p. 222-33 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  254. Published

    Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

    Junker, N., Thor Straten, P., Andersen, Mads Hald & Svane, Inge Marie, 2011, In: Journal of Skin Cancer. 2011, 574695, 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  255. Published

    Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip

    Selmeczi, D., Hansen, T., Met, Ö., Svane, Inge Marie & Larsen, N., 2011, In: Biomedical Microdevices. 13, 2, p. 383-92 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  256. Published

    Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

    Andersen, R. S., Sørensen, R. B., Ritter, C., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2011, In: Cancer Immunology, Immunotherapy. 60, 2, p. 227-34 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  257. Published

    Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

    Riley, C. H., Jensen, M. K., Brimnes, M. K., Hasselbalch, H. C., Bjerrum, O. W., Straten, P. T. & Svane, Inge Marie, 2011, In: Blood. 118, 8, p. 2170-3 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  258. Published

    Wildtype p53-specific Antibody and T-Cell Responses in Cancer Patients

    Pedersen, Anders Elm, Stryhn, A., Justesen, S., Harndahl, M., Rasmussen, S., Donskov, F., Claesson, Mogens Helweg, Pedersen, J. W., Wandall, Hans H., Svane, Inge Marie & Buus, Søren, 2011, In: Journal of Immunotherapy. 34, 9, p. 629-40 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  259. 2010
  260. Published

    Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⁻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma

    Brimnes, M. K., Vangsted, A. J., Knudsen, L. M., Gimsing, P., Gang, A. O., Johnsen, H. & Svane, Inge Marie, 1 Dec 2010, In: Scandinavian Journal of Immunology. 72, 6, p. 540-7 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  261. Published

    Safety and clinical effect of subcutaneous human interleukin-21 in patients with metastatic melanoma or renal cell carcinoma: a phase I trial

    Schmidt, H., Brown, J., Mouritzen, U., Selby, P., Fode, K., Svane, Inge Marie, Cook, G. P., Mollerup, D. H. & Geertsen, P. F., 1 Nov 2010, In: Clinical Cancer Research. 16, 21, p. 5312-9 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  262. Published

    Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

    Trepiakas, R., Berntsen, A., Hadrup, S. R., Bjørn, J., Geertsen, P. F., Straten, P. T., Andersen, Mads Hald, Pedersen, Anders Elm, Soleimani, A., Lorentzen, T., Johansen, Julia Sidenius & Svane, Inge Marie, 1 Oct 2010, In: Cytotherapy. 12, 6, p. 721-34 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  263. Published

    Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin

    Tsakiri, A., Tsiantoulas, D., Fredriksen, Jette Lautrup & Svane, Inge Marie, 1 Feb 2010, In: Experimental Neurology. 221, 2, p. 320-8 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  264. Published

    Therapeutic cancer vaccines in combination with conventional therapy

    Andersen, Mads Hald, Junker, N., Ellebaek, E., Svane, Inge Marie, Thor Straten, P. & Andersen, Mads Hald, 1 Jan 2010, In: Journal of Biomedicine and Biotechnology. 2010, p. 237623

    Research output: Contribution to journalJournal articleResearchpeer-review

  265. Published

    Combined Treatment with Dendritic Cell Vaccine and Low-Dose Cyclophosphamide in Patients with Malignant Melanoma

    Engell-Noerregaard, L., Ellebaek, E., Buch-Hansen, T. Z., Nikolajsen, K., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876-877 2 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  266. Published

    Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study

    Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  267. Published

    Increase of Circulating CD4(+)CD25(high)Foxp3(+) Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2

    Berntsen, A., Brimnes, M. K., Straten, P. T., Svane, Inge Marie, Berntsen, A., Brimnes, M. K., Straten, P. T. & Svane, Inge Marie, 2010, In: Journal of Immunotherapy. 33, 4, p. 425-434 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  268. Published

    Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2

    Berntsen, A., Brimnes, M. K., thor Straten, P. & Svane, Inge Marie, 2010, In: Journal of Immunotherapy. 33, 4, p. 425-34 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  269. Published

    Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⿻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma

    Brimnes, M. K., Vangsted, Annette Juul, Knudsen, L. M., Gimsing, P., Gang, Uffe Jakob Ortved, Johnsen, H. & Svane, Inge Marie, 2010, In: Scandinavian Journal of Immunology. 72, 6, p. 540-7

    Research output: Contribution to journalJournal articleResearchpeer-review

  270. Published

    Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial

    Buch-Hansen, T. Z., Sørensen, R. B., Mellemgaard, A., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 919-920 2 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  271. Published

    Therapeutic cancer vaccines

    Larsen, S. K., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 2010, In: Current Cancer Therapy Reviews. 6, 2, p. 163-174

    Research output: Contribution to journalJournal articleResearchpeer-review

  272. 2009
  273. Published

    Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function

    Trepiakas, R., Pedersen, Anders Elm, Met, Özcan & Svane, Inge Marie, 2009, In: Vaccine. 27, 16, p. 2213-9 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  274. Published

    CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53

    Sørensen, R. B., Andersen, R. S., Svane, Inge Marie, Engell-Noerregaard, L., Hadrup, S. R., Balslev, E., Andersen, Mads Hald & thor Straten, P., 2009, In: Clinical Cancer Research. 15, 5, p. 1543-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  275. Published

    Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

    Andersen, Mads Hald, Sørensen, R. B., Brimnes, M. K., Svane, Inge Marie, Becker, J. C. & thor Straten, P., 2009, In: Journal of Clinical Investigation. 119, 8, p. 2245-56 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  276. Published

    Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate

    Soleimani, A., Berntsen, A., Svane, Inge Marie & Pedersen, Anders Elm, 2009, In: Scandinavian Journal of Immunology. 70, 5, p. 481-9 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  277. Published

    Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes

    Kloverpris, H., Karlsson, I., Bonde, J., Thorn, M., Vinner, L., Pedersen, A., Hentze, J., Andresen, B., Svane, I., Gerstoft, J., Kronborg, G., Fomsgaard, A., Kloverpris, H., Karlsson, I., Bonde, J., Thorn, M., Vinner, L., Pedersen, A. E., Hentze, J. L., Andresen, B. S. & 4 others, Svane, I. M., Gerstoft, J., Kronborg, Gitte & Fomsgaard, A., 2009, In: AIDS. 23, 11, p. 1329-40 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  278. Published

    Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

    Engell-Noerregaard, L., Hansen, T. H., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 2009, In: Cancer Immunology, Immunotherapy. 58, 1, p. 1-14 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  279. Published

    The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag)

    Wenandy, L., Kollgaard, T., Letsch, A., Andersen, R. S., Stather, D., Seremet, T., Svane, Inge Marie, Vindeløv, L., Andersen, M. H. & thor Straten, P., 2009, In: Leukemia. 23, 10, p. 1926-9 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  280. Published

    The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase

    Sørensen, R. B., Berge-Hansen, L., Junker, N., Hansen, C. A., Hadrup, S. R., Schumacher, T. N. M., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: PLoS ONE. 4, 9, p. e6910

    Research output: Contribution to journalJournal articleResearchpeer-review

  281. Published

    The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines

    Sørensen, R. B., Junker, N., Kirkin, A., Voigt, H., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: Cancer Immunology, Immunotherapy. 58, 5, p. 665-75 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  282. 2008
  283. Published

    Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential

    Met, Özcan, Eriksen, J. & Svane, Inge Marie, Oct 2008, In: Molecular Biotechnology. 40, 2, p. 151-60 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  284. Published

    Cancer treatment: the combination of vaccination with other therapies

    Andersen, M. H., Sorensen, R. B., Schrama, D., Becker, J. C., Straten, P. T. & Svane, Inge Marie, 2008, In: Cancer Immunology, Immunotherapy. 57, 11, p. 1735-1743 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  285. Published

    Characterization of a single peptide derived from cytochrome P4501B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patients

    Kvistborg, P., Hadrup, S. R., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2008, In: Human Immunology. 69, 4-5, p. 266-272 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  286. Published

    Immunogenicity of the hTERT540-548 peptide in cancer

    Wenandy, L., Sorensen, R. B., Sengelov, L., Straten, P. T., Andersen, M. H. & Svane, Inge Marie, 2008, In: Clinical Cancer Research. 14, 1, p. 4-7 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  287. Published

    RhoC a new target for therapeutic vaccination against metastatic cancer

    Wenandy, L., Sorensen, R. B., Straten, P. T., Andersen, M. H. & Svane, Inge Marie, 2008, In: Cancer Immunology, Immunotherapy. 57, 12, p. 1871-1878 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  288. Published

    Studies on mRNA electroporation of immature and mature dendritic cells: Effects on their immunogenic potential

    Met, O., Eriksen, J. & Svane, Inge Marie, 2008, In: Journal of Molecular Microbiology and Biotechnology. 40, 2, p. 151-160 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  289. 2005
  290. Published

    Immunogenicity of Bcl-2 in patients with cancer

    Andersen, M. H., Svane, Inge Marie, Kvistborg, P., Nielsen, O. J., Balslev, E., Reker, S., Becker, J. C. & Straten, P. T., 15 Jan 2005, In: Blood. 105, 2, p. 728-34 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  291. 2003
  292. Published

    Clinical application of dendritic cells in cancer vaccination therapy

    Svane, Inge Marie, Soot, M. L., Buus, Søren & Johnsen, H. E., 2003, In: Acta Pathologica Microbiologica et Immunologica Scandinavica. 111, 7-8, p. 818-34 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4054758